Related Experiment Video

Updated: Jun 29, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Vascular factors in geriatric psychiatry: time to take a serious look

Leon Flicker1

  • 1Western Australian Centre for Health and Ageing, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. leonflic@cyllene.uwa.edu.au

Current Opinion in Psychiatry
|October 15, 2008
PubMed

Insights

Vascular risk factors are increasingly linked to cognitive decline and depression. While the exact cause is unclear, assessing and treating these factors in older adults may be beneficial.

Area of Science:

  • Neurology
  • Geriatrics
  • Cardiology

Background:

  • Vascular factors are increasingly implicated in cognitive decline and depression.
  • Understanding the relationship between vascular health and mental well-being is crucial.

Purpose of the Study:

  • To review the existing literature on the link between vascular risk factors, cognitive decline, and depression.
  • To explore the potential mechanisms and causal relationships.

Main Methods:

  • Literature review of studies investigating vascular risk factors and their association with cognitive decline and depression.
  • Analysis of evidence regarding the impact of vascular risk management.

Main Results:

  • Growing evidence suggests a significant association between vascular risk factors and increased risk of cognitive decline and depression.
  • The precise mechanisms and causality remain unclear.
  • Insufficient evidence currently exists to confirm that treating vascular risk factors reduces the subsequent risk of cognitive decline and depression.

Conclusions:

  • Given the mounting evidence, older patients experiencing cognitive decline and depression should undergo assessment and treatment for vascular risk factors.
  • Treating vascular risk factors offers established cardiovascular benefits, potentially offering a dual benefit for brain health and overall well-being.
Abstract

More Related Videos

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma06:40

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma

Published on: March 11, 2022

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...